Literature DB >> 21431680

Chemical modification of small interfering RNA.

Jesper B Bramsen1, Jørgen Kjems.   

Abstract

Chemically synthesized siRNAs are widely used for gene silencing. For in vitro applications, stability, delivery, and immunological issues are rarely problematic, but for in vivo applications the situation is different. Limited stability, undesirable pharmacokinetic behaviour, and unanticipated side effects from the immune system call for more careful structural siRNA design and inclusion of chemical modifications at selected positions. Also the notion that siRNA induces significant off-target silencing of many non-related genes has promted new effective measures to enhance specificity. The scope of this review is to provide a simple guide to successful chemical and structural modification of siRNAs with improved activity, stability, specificity, and low toxicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21431680     DOI: 10.1007/978-1-61779-037-9_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  17 in total

Review 1.  Chemical modification of siRNA bases to probe and enhance RNA interference.

Authors:  Hayden Peacock; Arunkumar Kannan; Peter A Beal; Cynthia J Burrows
Journal:  J Org Chem       Date:  2011-08-17       Impact factor: 4.354

2.  Single-stranded microRNA mimics.

Authors:  Guillaume Chorn; Molly Klein-McDowell; Lihong Zhao; Matthew A Saunders; W Michael Flanagan; Aarron T Willingham; Lee P Lim
Journal:  RNA       Date:  2012-08-21       Impact factor: 4.942

3.  The Use of Minimal RNA Toeholds to Trigger the Activation of Multiple Functionalities.

Authors:  Kirill A Afonin; Mathias Viard; Philip Tedbury; Eckart Bindewald; Lorena Parlea; Marshall Howington; Melissa Valdman; Alizah Johns-Boehme; Cara Brainerd; Eric O Freed; Bruce A Shapiro
Journal:  Nano Lett       Date:  2016-02-29       Impact factor: 11.189

4.  Efficient delivery of RNAi prodrugs containing reversible charge-neutralizing phosphotriester backbone modifications.

Authors:  Bryan R Meade; Khirud Gogoi; Alexander S Hamil; Caroline Palm-Apergi; Arjen van den Berg; Jonathan C Hagopian; Aaron D Springer; Akiko Eguchi; Apollo D Kacsinta; Connor F Dowdy; Asaf Presente; Peter Lönn; Manuel Kaulich; Naohisa Yoshioka; Edwige Gros; Xian-Shu Cui; Steven F Dowdy
Journal:  Nat Biotechnol       Date:  2014-11-17       Impact factor: 54.908

Review 5.  Progress toward in vivo use of siRNAs-II.

Authors:  Garrett R Rettig; Mark A Behlke
Journal:  Mol Ther       Date:  2011-12-20       Impact factor: 11.454

6.  Adenosine modification may be preferred for reducing siRNA immune stimulation.

Authors:  Raymond V Fucini; Henry J Haringsma; Patricia Deng; W Michael Flanagan; Aarron T Willingham
Journal:  Nucleic Acid Ther       Date:  2012-04-20       Impact factor: 5.486

7.  The immunorecognition, subcellular compartmentalization, and physicochemical properties of nucleic acid nanoparticles can be controlled by composition modification.

Authors:  Morgan Brittany Johnson; Justin R Halman; Daniel K Miller; Joseph S Cooper; Emil F Khisamutdinov; Ian Marriott; Kirill A Afonin
Journal:  Nucleic Acids Res       Date:  2020-11-18       Impact factor: 16.971

Review 8.  Functional genomic and high-content screening for target discovery and deconvolution.

Authors:  Susanne Heynen-Genel; Lars Pache; Sumit K Chanda; Jonathan Rosen
Journal:  Expert Opin Drug Discov       Date:  2012-08-04       Impact factor: 6.098

Review 9.  RNA interference-based therapy and its delivery systems.

Authors:  Xiuhui Chen; Lingegowda S Mangala; Cristian Rodriguez-Aguayo; Xianchao Kong; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Cancer Metastasis Rev       Date:  2018-03       Impact factor: 9.264

10.  A cationic amphiphilic co-polymer as a carrier of nucleic acid nanoparticles (Nanps) for controlled gene silencing, immunostimulation, and biodistribution.

Authors:  Justin R Halman; Ki-Taek Kim; So-Jung Gwak; Richard Pace; M Brittany Johnson; Morgan R Chandler; Lauren Rackley; Mathias Viard; Ian Marriott; Jeoung Soo Lee; Kirill A Afonin
Journal:  Nanomedicine       Date:  2019-10-25       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.